US Patent Issued to The Board of Regents of the University of Texas System, Universite de Strasbourg, Institut National de la Sante et de la Recherche Medicale (INSERM), Hopitaux Universitaires de Strasbourg (HUS) on Jan. 13 for "Methods for the assessment of risk and treatments for liver cancers and lethal liver disease complications" (American, Japanese, German Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,523,658, issued on Jan. 13, was assigned to The Board of Regents of the University of Texas System (Austin, Texas), Universite de Strasbourg (Strasbourg, France), Institut National de la Sante et de la Recherche Medicale (INSERM) (Paris) and Hopitaux Universitaires de Strasbourg (HUS) (Strasbourg, France).

"Methods for the assessment of risk and treatments for liver cancers and lethal liver disease complications" was invented by Yujin Hoshida (Dallas), Naoto Fujiwara (Tsu, Japan), Amit G. Singal (Dallas) and Thomas F. Baumert (Freiburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosures herein are directed to methods and compositions for...